DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease
Translational Neurodegeneration, 2024
Appleton E., Khosousi S., Ta M., Nalls M., Singleton A., Sturchio A., Markaki I., Paslawski W., Iwaki H., Svenningsson P.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Neurology | Patient Stratification | Plasma CSF |  Olink Target 96  Olink Explore 3072/384 |
Abstract
n/a